A handful of biotech stocks were catapulted higher by short squeezes. Whether they will recover their losses is an open question.

The genomics company PacBio isn't making much progress in the most important source of revenue.

Shares of the genetic testing company have more than doubled in less than a week. It likely isn't durable.

DNA-sequencing leader Illumina swung to a loss in Q2 2022. Contributions from Grail didn't help.

The formerly high-flying growth stock is stalling against macroeconomic headwinds. How quickly can the business get back on track?

This lab-hardware business is growing, cashed up, and close to profitability.

On Wednesday, Ark snapped up shares of Twilio, Roblox, Coinbase and JD.com. It sold Twitter and Palantir Technologies.

Invitae says a $1.15 billion investment from a Softbank-led group will support the medical-genetics company's growth opportunities.

Pacific Biosciences says Softbank's $900 million investment 'validates our leadership position in the long-read DNA sequencing market.'

Tesla is expected to start production of its highly anticipated futuristic truck in 2023.

A development team led by Seth Rogen is working on a production that centers on a less well-known character with a nonetheless devoted following.

The Fed's preferred inflation gauge topped Street forecasts Friday, snuffing out hopes of a near-term change in the central bank's rate hiking plans.